Unknown

Dataset Information

0

Systemic Immunotherapy Effective for Refractory Extramedullary Acute Myeloid Leukemia.

ABSTRACT:

SUBMITTER: Alfayez M 

PROVIDER: S-EPMC6448807 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Systemic Immunotherapy Effective for Refractory Extramedullary Acute Myeloid Leukemia.

Alfayez Mansour M   Ivan Doina D   Pemmaraju Naveen N   Daver Naval N   DiNardo Courtney D CD  

JCO precision oncology 20190206

Similar Datasets

Unknown Inotuzumab ozogamicin is effective in relapsed/refractory extramedullary B acute lymphoblastic leukemia.
| S-EPMC6238377 | biostudies-literature
Unknown Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia.
| S-EPMC7885824 | biostudies-literature
Unknown Isolated leukemia cutis as extramedullary relapse of acute myeloid leukemia.
| S-EPMC9354096 | biostudies-literature
Unknown Acute myeloid leukemia with CPSF6-RARG fusion resembling acute promyelocytic leukemia with extramedullary infiltration.
| S-EPMC7797573 | biostudies-literature
Unknown Heterogeneity in refractory acute myeloid leukemia.
| S-EPMC6535032 | biostudies-literature
Unknown ¹⁸F-FDG-PET/CT for detection of extramedullary acute myeloid leukemia.
| S-EPMC3186319 | biostudies-literature
Unknown Spatial heterogeneity and differential treatment response of acute myeloid leukemia and relapsed/refractory extramedullary disease after allogeneic hematopoietic cell transplantation.
| S-EPMC9425876 | biostudies-literature
Unknown Treatment for Relapsed/Refractory Acute Myeloid Leukemia.
| S-EPMC8171365 | biostudies-literature
Unknown Emerging Immunotherapy for Acute Myeloid Leukemia.
| S-EPMC7920435 | biostudies-literature
Unknown CD7-directed CAR T-cell therapy: a potential immunotherapy strategy for relapsed/refractory acute myeloid leukemia.
| S-EPMC9523980 | biostudies-literature